The company has provincial-level<±π research and development p≠​latforms such as the "•♦Jiangsu Animal Disease Prevention and Con‍∞♣Ωtrol Bioengineering T₽✘•echnology Research Center", &↓✘quot;Jiangsu Province Certified Enterprise Techno>®♠logy Center", "Jiangsu Province Postdocφ"λφtoral Innovation Practice Base", and ♥←"Jiangsu Province Graduate Workstatio≈λ§n", as well as municipal le→♠☆★vel research and devel≥Ωopment platforms such as the "Wuxi Academic∏​≈ian Workstation" and "Jiangyin Aca¶ demician Workstation¶ δ®". The company has↔π§∞ established long-term and stable industry univer≈≠♦sity research cooperation relationships with•< well-known domestic research institutes such a‌ φ s the School of Veterina≠ε≥÷ry Medicine at Nanjing Agri  ε✔cultural University, Jiangnan University, th★₩ ₩e School of Veterinary Medici‍'λ≈ne at Yangzhou University, Jiangsu Academy of Agr♥ icultural Sciences, an✔<d Harbin Veterinary Research Institute. In rece♥  >nt years, we have undertaken more thanβ∏ 20 projects from national,  ♣provincial, and municipal sci®≤∏ence and technology departments, obtained 15 inΩ★"&vention patents, and obtained 15 national new vet±≠"αerinary drug certificaγ♣✘tes.

By 2023, the company will be the only bio•εpharmaceutical enterprise απin Wuxi specializing in the producti<λon of livestock and poultry vaccines, ∑∞and also the largest high-tech private enterprise"& in Jiangsu Province specializing in the produc  tion of livestock and pou↔✘•ltry vaccines; With the deepening of the comp♦₽≤any's technological innovati₽™on work item by item, the company has fo ​÷rmed a mature research and innovation sy↓✔♣™stem that integrates industry univer←★✘sity research cooperation. With the support of t♦☆∏he company's strong technical teamσ→↕, it continuously strengthens cooperation wi₹©th well-known domestic research institut§φions, industry university researcλ↑γh cooperation, and scientific resea≥γαrch cooperation with similar enterprises t×✔©o jointly develop livestock and pou☆‌≠ltry vaccine related technologies. I&₩t closely combines with the forefront o★β​λf breeding and adopts the la₽∏§÷test technologies suchδ≠ as reverse genetics and gene re✘✘combination to conduc ☆♠Ωt new product research and developm♥↓‍₩ent, improve market competitivene♦♣→ss, and currently ranks among the top fifte♠₽en in the industry in annual sales; The pig ri✔βng vaccine series products have maintai‍•σned a leading market •™€share in the country for 15 consecutive ♥λ₩years, with the market share✘ε‌ of recombinant Newcastle disease virus inα$activated vaccines continuing to lead. The ↓ε♠÷market share of swine fe£ $±ver live vaccines and pseu¶∏εdo rabies live vaccines ra"$nks among the top in the industr♦✔↓y; Research and innovation capabilities, with ×∑annual rankings of the top ten scientific researβ♥₹ch achievements and technological levels in the γ ↔industry; The high-end ma•δ≠♥rket share of large-sβ•≤≥cale aquaculture groups exceeds that of i♦£ mported vaccines.